10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2020 | |||
Consolidated Statements of Earnings | |||
Period Ending Jan 3, 2021 10-K (Filed: Feb 22, 2021) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 3, 2021 | Dec 29, 2019 | Dec 30, 2018 | |
| Sales to customers | $ 82,584 | 82,059 | 81,581 |
| Cost of products sold | 28,427 | 27,556 | 27,091 |
| Gross profit | 54,157 | 54,503 | 54,490 |
| Selling, marketing and administrative expenses | 22,084 | 22,178 | 22,540 |
| Research and development expense | 12,159 | 11,355 | 10,775 |
| In-process research and development (Note 5) | 181 | 890 | 1,126 |
| Interest income | (111) | (357) | (611) |
| Interest expense, net of portion capitalized (Note 4) | 201 | 318 | 1,005 |
| Other (income) expense, net | 2,899 | 2,525 | 1,405 |
| Restructuring (Note 20) | 247 | 266 | 251 |
| Earnings before provision for taxes on income | 16,497 | 17,328 | 17,999 |
| Provision for taxes on income (Note 8) | 1,783 | 2,209 | 2,702 |
| Net earnings | 14,714 | 15,119 | 15,297 |
| Net earnings per share (Notes 1 and 15) | |||
| Basic (in dollars per share) | 5.59 | 5.72 | 5.70 |
| Diluted (in dollars per share) | 5.51 | 5.63 | 5.61 |
| Average shares outstanding (Notes 1 and 15) | |||
| Basic (in shares) | 2,632,800 | 2,645,100 | 2,681,500 |
| Diluted (in shares) | 2,670,700 | 2,684,300 | 2,728,700 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2020 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Jan 3, 2021 10-K (Filed: Feb 22, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 3, 2021 | Dec 29, 2019 | Dec 30, 2018 | |
| Net earnings | $ 14,714 | 15,119 | 15,297 |
| Other Comprehensive Income (Loss), net of tax | |||
| Foreign currency translation | (233) | 164 | (1,518) |
| Securities | |||
| Unrealized holding gain (loss) arising during period | 1 | 0 | (1) |
| Reclassifications to earnings | 0 | 0 | 1 |
| Net change | 1 | 0 | 0 |
| Employee benefit plans | |||
| Prior service credit (cost), net of amortization | 1,298 | (18) | (44) |
| Gain (loss), net of amortization | (1,135) | (714) | (56) |
| Effect of exchange rates | (229) | (1) | 92 |
| Net change | (66) | (733) | (8) |
| Derivatives & hedges | |||
| Unrealized gain (loss) arising during period | 1,000 | (107) | (73) |
| Reclassifications to earnings | (53) | 7 | (192) |
| Net change | 947 | (100) | (265) |
| Other comprehensive income (loss) | 649 | (669) | (1,791) |
| Comprehensive income | 15,363 | 14,450 | 13,506 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2020 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Jan 3, 2021 10-K (Filed: Feb 22, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 3, 2021 | Dec 29, 2019 | Dec 30, 2018 | |
| Cash flows from operating activities | |||
| Net earnings | $ 14,714 | 15,119 | 15,297 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 7,231 | 7,009 | 6,929 |
| Stock based compensation | 1,005 | 977 | 978 |
| Asset write-downs | 233 | 1,096 | 1,258 |
| Contingent consideration reversal | (1,148) | 0 | 0 |
| Net gain on sale of assets/businesses | (111) | (2,154) | (1,217) |
| Deferred tax provision | (1,141) | (2,476) | (1,016) |
| Credit losses and accounts receivable allowances | 63 | (20) | (31) |
| Changes in assets and liabilities, net of effects from acquisitions and divestitures: | |||
| Decrease/(Increase) in accounts receivable | 774 | (289) | (1,185) |
| Increase in inventories | (265) | (277) | (644) |
| Increase in accounts payable and accrued liabilities | 5,141 | 4,060 | 3,951 |
| Increase in other current and non-current assets | (3,704) | (1,054) | (275) |
| Increase/(Decrease) in other current and non-current liabilities | 744 | 1,425 | (1,844) |
| Net cash flows from operating activities | 23,536 | 23,416 | 22,201 |
| Cash flows from investing activities | |||
| Additions to property, plant and equipment | (3,347) | (3,498) | (3,670) |
| Proceeds from the disposal of assets/businesses, net | 305 | 3,265 | 3,203 |
| Acquisitions, net of cash acquired (Note 18) | (7,323) | (5,810) | (899) |
| Purchases of investments | (21,089) | (3,920) | (5,626) |
| Sales of investments | 12,137 | 3,387 | 4,289 |
| Credit support agreements activity, net | (987) | 338 | 0 |
| Other (primarily licenses and milestones) | (521) | 44 | (464) |
| Net cash used by investing activities | (20,825) | (6,194) | (3,167) |
| Cash flows from financing activities | |||
| Dividends to shareholders | (10,481) | (9,917) | (9,494) |
| Repurchase of common stock | (3,221) | (6,746) | (5,868) |
| Proceeds from short-term debt | 3,391 | 39 | 80 |
| Repayment of short-term debt | (2,663) | (100) | (2,479) |
| Proceeds from long-term debt, net of issuance costs | 7,431 | 3 | 5 |
| Repayment of long-term debt | (1,064) | (2,823) | (1,555) |
| Proceeds from the exercise of stock options/employee withholding tax on stock awards, net | 1,114 | 954 | 949 |
| Credit support agreements activity, net | (333) | 100 | 25 |
| Other | (294) | 475 | (173) |
| Net cash used by financing activities | (6,120) | (18,015) | (18,510) |
| Effect of exchange rate changes on cash and cash equivalents | 89 | (9) | (241) |
| (Decrease)/Increase in cash and cash equivalents | (3,320) | (802) | 283 |
| Cash and cash equivalents, beginning of year (Note 1) | 17,305 | 18,107 | |
| Cash and cash equivalents, end of year (Note 1) | 13,985 | 17,305 | 18,107 |
| Supplemental cash flow data | |||
| Cash paid during the year for: | |||
| Interest | 904 | 995 | 1,049 |
| Interest, net of amount capitalized | 841 | 925 | 963 |
| Income taxes | 4,619 | 4,191 | 4,570 |
| Supplemental schedule of non-cash investing and financing activities | |||
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards | 1,937 | 1,736 | 2,095 |
| Conversion of debt | 27 | 1 | 6 |
| Acquisitions | |||
| Fair value of assets acquired | 7,755 | 7,228 | 1,047 |
| Fair value of liabilities assumed and noncontrolling interests | (432) | (1,418) | (148) |
| Net cash paid for acquisitions (Note 18) | 7,323 | 5,810 | 899 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2020 | ||
Consolidated Balance Sheets | ||
Period Ending Jan 3, 2021 10-K (Filed: Feb 22, 2021) | ||
| (In Millions, except shares in Thousands) | ||
| As of | As of | |
| Jan 3, 2021 | Dec 29, 2019 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 13,985 | 17,305 |
| Marketable securities (Notes 1 and 2) | 11,200 | 1,982 |
| Accounts receivable trade, less allowances for doubtful accounts $293 (2019, $226) | 13,576 | 14,481 |
| Inventories (Notes 1 and 3) | 9,344 | 9,020 |
| Prepaid expenses and other receivables | 3,132 | 2,392 |
| Assets held for sale (Note 18) | 0 | 94 |
| Total current assets | 51,237 | 45,274 |
| Property, plant and equipment, net (Notes 1 and 4) | 18,766 | 17,658 |
| Intangible assets, net (Notes 1 and 5) | 53,402 | 47,643 |
| Goodwill (Notes 1 and 5) | 36,393 | 33,639 |
| Deferred taxes on income (Note 8) | 8,534 | 7,819 |
| Other assets | 6,562 | 5,695 |
| Total assets | 174,894 | 157,728 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Loans and notes payable (Note 7) | 2,631 | 1,202 |
| Accounts payable | 9,505 | 8,544 |
| Accrued liabilities | 13,968 | 9,715 |
| Accrued rebates, returns and promotions | 11,513 | 10,883 |
| Accrued compensation and employee related obligations | 3,484 | 3,354 |
| Accrued taxes on income (Note 8) | 1,392 | 2,266 |
| Total current liabilities | 42,493 | 35,964 |
| Long-term debt (Note 7) | 32,635 | 26,494 |
| Deferred taxes on income (Note 8) | 7,214 | 5,958 |
| Employee related obligations (Notes 9 and 10) | 10,771 | 10,663 |
| Long-term taxes payable (Note 1) | 6,559 | 7,444 |
| Other liabilities | 11,944 | 11,734 |
| Total liabilities | 111,616 | 98,257 |
| Shareholders' equity: | ||
| Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (15,242) | (15,891) |
| Retained earnings | 113,890 | 110,659 |
| Stockholders' Equity before Treasury Stock | 101,768 | 97,888 |
| Less: common stock held in treasury, at cost (Note 12) (487,331,000 shares and 487,336,000 shares) | 38,490 | 38,417 |
| Total shareholders equity | 63,278 | 59,471 |
| Total liabilities and shareholders equity | 174,894 | 157,728 |
| Preferred stock, shares authorized (in shares) | 2,000 | 2,000 |
| Common Stock, Par or Stated Value Per Share | 1.0000 | 1.0000 |
| Common Stock, Shares Authorized | 4,320,000 | 4,320,000 |
| Common Stock, Shares, Issued | 3,119,843 | 3,119,843 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |